These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 25622691)
21. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Kase CS; Furlan AJ; Wechsler LR; Higashida RT; Rowley HA; Hart RG; Molinari GF; Frederick LS; Roberts HC; Gebel JM; Sila CA; Schulz GA; Roberts RS; Gent M Neurology; 2001 Nov; 57(9):1603-10. PubMed ID: 11706099 [TBL] [Abstract][Full Text] [Related]
22. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke. Tütüncü S; Ziegler AM; Scheitz JF; Slowinski T; Rocco A; Endres M; Nolte CH Stroke; 2013 Nov; 44(11):3217-9. PubMed ID: 24003042 [TBL] [Abstract][Full Text] [Related]
23. Intravenous rt-PA is not associated with increased risk of hemorrhage in patients with intracranial aneurysms. Sheth KN; Shah N; Morovati T; Hermann LD; Cronin CA Neurocrit Care; 2012 Oct; 17(2):199-203. PubMed ID: 22752394 [TBL] [Abstract][Full Text] [Related]
24. Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients. Chen Y; Li CH; Wang YX; Zhang CH; Dong Z; Zhang FF; Wang JH; Zhang PL Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1852-8. PubMed ID: 26044231 [TBL] [Abstract][Full Text] [Related]
25. Ventricular extension of intracerebral hemorrhage during intravenous thrombolysis. Harston GW; Tee YK; Jones M; Payne S; Pope G; Sheerin F; Kennedy J Cerebrovasc Dis; 2013; 36(4):324-5. PubMed ID: 24193034 [No Abstract] [Full Text] [Related]
26. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333 [TBL] [Abstract][Full Text] [Related]
27. Predicting risk of symptomatic intracerebral hemorrhage and mortality after treatment with recombinant tissue-plasminogen activator using SEDAN score. Al-Khaled M; Langner B; Brüning T Acta Neurol Scand; 2016 Apr; 133(4):239-44. PubMed ID: 26033162 [TBL] [Abstract][Full Text] [Related]
28. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192 [TBL] [Abstract][Full Text] [Related]
38. Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis. Seet RC; Zhang Y; Moore SA; Wijdicks EF; Rabinstein AA Stroke; 2011 Aug; 42(8):2333-5. PubMed ID: 21659639 [TBL] [Abstract][Full Text] [Related]
39. The smoking-thrombolysis paradox and acute ischemic stroke. Fisher M Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964 [No Abstract] [Full Text] [Related]